Skip to main content
Fig. 1 | Cardiovascular Diabetology

Fig. 1

From: Telomere length as biomarker of nutritional therapy for prevention of type 2 diabetes mellitus development in patients with coronary heart disease: CORDIOPREV randomised controlled trial

Fig. 1

Association between risk of short telomeres and T2DM incidence. Participant frequency (A) and Odds Ratio (B) of T2DM incidence according to the risk of short telomeres. Mosaic plots: Height of bars represents proportions of participants at risk or no risk of short telomere, the width of each bar is proportional to T2DM incidence. The analysis were performed applying the Fisher’s exact test (A) and logistic association, Odds ratios and 95% confident intervals of T2DM incidence adjusted by age, gender BMI, WC, HbA1c, triglycerides, HDL-c and family history of both diabetes and early coronary heart disease (B)

Back to article page